“Need to Focus On Corp Governance”
  • Saba Ashraf
  • Jul 25 2013

July 25: When it comes to pharma, companies seem to be running into trouble with the USFDA. “There is a need to focus on corporate governance and quality,” says B.P. Singh, Executive Director and CIO – Equity at Pramerica Mutual Fund. “We like unleveraged companies and have a strong bias for IT and pharma stocks.”